Skip to main content
SURAKSHA DIAGNOSTIC LIMITED logo

SURAKSHA DIAGNOSTIC LIMITED — Investor Relations & Filings

Ticker · SURAKSHA ISIN · INE877V01027 LEI · 335800SJSOH7ZQHTPO56 BSE.NS Human health and social work activities
Open in API
Filings indexed 144 across all filing types
Latest filing 2024-12-20 Regulatory Filings
Country IN India
Listing BSE.NS SURAKSHA

About SURAKSHA DIAGNOSTIC LIMITED

https://www.surakshanet.com

Suraksha Diagnostic Limited is a prominent diagnostic healthcare service provider primarily operating in Eastern India. The company offers a comprehensive range of pathology and radiology services, including clinical laboratory tests, molecular diagnostics, and advanced imaging such as MRI, CT scans, ultrasound, and X-rays. It operates a network of diagnostic centers and polyclinics, providing integrated healthcare solutions that encompass specialized consultations and preventive health check-ups. The organization is recognized for its commitment to quality, maintaining international standards through NABL and CAP accreditations. By leveraging advanced medical technology and a robust logistics framework for home collection, the company serves a diverse patient base, focusing on accurate clinical outcomes and accessible diagnostic care.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2024-12-20 English
Outcome of Board Meeting
Regulatory Filings
2024-12-20 English
Outcome of Board Meeting
Regulatory Filings
2024-12-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about an upcoming conference call scheduled for December 23, 2024, to discuss the company's Q2 and H1 FY25 financial results. It explicitly states that this is an 'Earnings Call' for analysts and institutional investors. The document includes details about the event, participants, dial-in numbers, and instructions for pre-registration. It does not contain actual financial statements or detailed financial analysis but serves as an announcement of the earnings call event. According to the classification rules, such a document announcing an earnings call is best classified as a Call Transcript (CT) category, as it relates to the full text transcript or announcement of a conference call. However, since this document is only the announcement of the earnings call and not the transcript itself, the best fitting category is Call Transcript (CT) because it is about the earnings call event. Confidence is high due to clear references to the earnings call and the nature of the document as an event notice.
2024-12-18 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-12-14 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for 20 December 2024. The purpose of the meeting is to consider and approve unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2024. The letter also mentions the closure of the trading window in compliance with insider trading regulations. The document is an announcement of a Board Meeting and does not contain any financial data or results itself. It is a regulatory compliance notification under SEBI regulations about the scheduling of a board meeting to approve interim financial results. Therefore, this document fits the category of Board/Management Information (MANG) as it relates to board meeting scheduling and compliance disclosures.
2024-12-14 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.